Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Pulsatilla chinensis compounds may help prevent stress-related hair loss.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Carthamus oxyacantha may help treat BPH by inhibiting 5α-reductase.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Targeting the Smoothened receptor shows promise for treating certain cancers.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

The diphosphonate was the most effective at preventing calcification in rats.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

Retinoids may help treat lupus nephritis and reduce steroid use.

Rothmund-Thomson syndrome type 2 can cause chronic, poorly healing wounds.